ArticleJournal of the Optical Society of America. A, Optics, image science, and vision2025
Application of the angular indication measurement and foraging interactive D-prime paradigms to tablet-based color vision testing.
Article in Journal of the Optical Society of America. A, Optics, image science, and vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of Angular Indication Measurement (AIM) Stereoacuity.medRxiv : the preprint server for health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Numerous computer-based tests are available for evaluating color vision deficiencies (CVD). Here we demonstrate the application of two paradigms-the angular indication measurement (AIM) and the foraging interactive D-prime (FInD)-to a tablet-based assessment of color detection and discrimination. Comparison between the anomaloscope and all other tests, including the CCT, the Mollon-Reffin test, and the AIM and FInD tests, showed good agreement in identifying color deficiencies. The defect-type classification revealed that AIM color discrimination showed the highest agreement with anomaloscopy, whereas AIM color detection showed the lowest agreement. The combination of either AIM or FInD detection and discrimination data resulted in an even better agreement than any single test. The results suggest that the AIM and FInD tablet tests provide relatively rapid, useful, and informative CVD screening with portability suitable for field research and the clinic.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.